Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-015026
Filing Date
2016-03-02
Accepted
2016-03-02 17:30:25
Documents
1
Period of Report
2016-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4076
  Complete submission text file 0000899243-16-015026.txt   5682
Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REGENXBIO INC. 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address
Ali Faraz (Reporting) CIK: 0001667937 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37553 | Film No.: 161478493